Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Generex Biotechnology Corporation
(OP:
GNBT
)
0.0275
USD
+0.0005 (+1.85%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Generex Biotechnology Corporation
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Key to Success, How to Profit: CIRC, TAGG, CBIS and GNBT
December 21, 2012
from
Marketwired News Releases
AP Pharma Inc. (OTC:APPA), Liquidmetal Technologies Inc. (OTC:LQMT), Generex Biotechnology Corp. (OTC:GNBT), and Applied DNA Sciences Inc. (OTC:APDN), Have Been Added to Growing Stock Report's Afterno
December 20, 2012
New York, NY -- (SBWIRE) -- 12/20/2012 -- Growing Stock Report iniates an Afternoon OTC Watch List and Investor Poll for the following stocks: AP Pharma Inc. (OTC:APPA), Liquidmetal Technologies Inc....
Read More
from
SBWire - Latest Press Releases
Financial Commitment Analysts' Downgrades for Today (LNET, FINL, GNBT, SGY)
December 18, 2012
New York, NY -- (SBWIRE) -- 12/18/2012 -- PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We...
Read More
from
SBWire - Latest Press Releases
Generex Biotechnology Corporation (OTC:GNBT) on a Highway to SubPennyLand
December 13, 2012
Today's story is devoted to a debt-ridden penny stock that has been around for 17 years and has so far failed to take on a positive course towards financial stability. The stock in question is Generex...
Read More
category
Stocks
from
Hotstocked.com articles
Generex Announces $750,000 Capital Investment
December 11, 2012
from
PR Newswire
Healthcare Stocks to Avoid Today (NKTR, GNBT, MRK, DVAX)
November 14, 2012
Los Angelas, CA -- (SBWIRE) -- 11/14/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
Generex Provides Update on Company Initiatives Including the AE37 Breast Cancer Vaccine Program
November 13, 2012
from
PR Newswire
OTC Stocks Trading Mixed: GNBT, MFTH, ELAY, STKO, GFMH
November 09, 2012
Las Vegas, NV -- (SBWIRE) -- 11/09/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by Beststocksdaily....
Read More
from
SBWire - Latest Press Releases
Generex Management Provides Update to Stockholders
September 20, 2012
from
PR Newswire
Notable Movers (GNBT, LTON, AKS, AEZS, SWFT)
September 18, 2012
Lakeway, TX -- (SBWIRE) -- 09/18/2012 -- Marketsareopen, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Top AMEX Active Stocks. Read the full...
Read More
from
SBWire - Latest Press Releases
These 4 Penny Stocks Alerts Useful for Investor ( GNBT, SNSS, GBG, SN )
September 13, 2012
Los Angelas, CA -- (SBWIRE) -- 09/13/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
Generex Biotechnology Announces Presentation of Early Results Showing Activity of Cancer Vaccine in Patients with Triple Negative Breast Cancer
September 13, 2012
from
PR Newswire
Generex Addresses Recent Trading Volume in Shares of its Common Stock
September 12, 2012
from
PR Newswire
Generex Announces $750,000 Capital Investment
August 08, 2012
from
PR Newswire
Mentor Capital Cancer Immunotherapy Index Gains 29% During First Half of 2012
July 23, 2012
from
Business Wire News Releases
Generex Provides Update on Generex's Flagship Product Oral-lyn™ in India
June 25, 2012
from
PR Newswire
Generex Announces Results of Annual Stockholders' Meeting
June 20, 2012
Company announces addition of oncology biostatistician to Antigen Express AE37 breast cancer vaccine working group; provides update on EOP2 meeting
Read More
from
PR Newswire
Women's Issues Feature Package
June 20, 2012
from
PR Newswire
Generex Announces Publication of Abstract at ASCO 2012 Showing Potential of Antigen Express AE37 Immunotherapeutic Cancer Vaccine Technology in Prostate Cancer
June 14, 2012
from
PR Newswire
Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
June 13, 2012
from
PR Newswire
Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
June 08, 2012
Drs. Samuel Jacobs, MD and Gary H. Lyman, MD join SAB
Read More
from
PR Newswire
INVE, GNBT and ECOB are the Stocks to Watch for June 7th from OTCPicks.com
June 08, 2012
from
EmailWire.Com Press Releases
Generex Announces Presentation of New Immune Response Data from AE37 Phase II Breast Cancer Trial at ASCO 2012
June 07, 2012
from
PR Newswire
Generex Announces ASCO 2012 Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology
June 07, 2012
Abstract receives a 2012 Conquer Cancer Foundation of ASCO Merit Award
Read More
from
PR Newswire
Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
June 07, 2012
Meeting Scheduled For June 18, 2012
Read More
from
PR Newswire
Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
June 07, 2012
Meeting Scheduled For June 18, 2012
Read More
from
PR Newswire
INVE, GNBT, CBIS and ECOB are the Daily Market Movers for June 7th from OTCPicks.com
June 07, 2012
from
EmailWire.Com Press Releases
Generex Announces ASCO 2012 Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology
June 06, 2012
Abstract receives a 2012 Conquer Cancer Foundation of ASCO Merit Award
Read More
from
PR Newswire
Generex Announces Presentation of New Immune Response Data from AE37 Phase II Breast Cancer Trial at ASCO 2012
June 05, 2012
from
PR Newswire
Generex Augments Antigen Express Scientific Advisory Board
May 18, 2012
Drs. Ian Krop, MD, PhD and Nuhad Ibrahim, MD join SAB
Read More
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.